These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 21736424)
1. Enhancement of Gag-specific but reduction of Env- and Pol-specific CD8+ T cell responses by simian immunodeficiency virus nonstructural proteins in mice. Zhang Y; Sun C; Feng L; Xiao L; Chen L AIDS Res Hum Retroviruses; 2012 Apr; 28(4):374-83. PubMed ID: 21736424 [TBL] [Abstract][Full Text] [Related]
2. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys. Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628 [TBL] [Abstract][Full Text] [Related]
3. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins. Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331 [TBL] [Abstract][Full Text] [Related]
4. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques. Venet A; Bourgault I; Aubertin AM; Kiény MP; Levy JP J Immunol; 1992 May; 148(9):2899-908. PubMed ID: 1349322 [TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression. Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473 [TBL] [Abstract][Full Text] [Related]
9. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model. Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888 [TBL] [Abstract][Full Text] [Related]
10. Substantial envelope-specific CD8 T-cell immunity fails to control SIV disease. Peut V; Kent SJ Virology; 2009 Feb; 384(1):21-7. PubMed ID: 19091370 [TBL] [Abstract][Full Text] [Related]
11. SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques. Boyer JD; Robinson TM; Kutzler MA; Parkinson R; Calarota SA; Sidhu MK; Muthumani K; Lewis M; Pavlakis G; Felber B; Weiner D J Med Primatol; 2005 Oct; 34(5-6):262-70. PubMed ID: 16128921 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection. Soloff AC; Liu X; Gao W; Day RD; Gambotto A; Barratt-Boyes SM Eur J Immunol; 2009 Sep; 39(9):2437-49. PubMed ID: 19670380 [TBL] [Abstract][Full Text] [Related]
13. No difference in Gag and Env immune-response profiles between vaccinated and non-vaccinated rhesus macaques that control immunodeficiency virus replication. Nieuwenhuis I; Beenhakker N; Bogers WM; Otting N; Bontrop RE; Dubois P; Mooij P; Heeney JL; Koopman G J Gen Virol; 2010 Dec; 91(Pt 12):2974-84. PubMed ID: 20826621 [TBL] [Abstract][Full Text] [Related]
15. Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys. Sun C; Zhang L; Zhang M; Liu Y; Zhong M; Ma X; Chen L J Infect; 2010 May; 60(5):371-81. PubMed ID: 20227437 [TBL] [Abstract][Full Text] [Related]
16. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses. Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A J Immunol Methods; 2004 Aug; 291(1-2):153-63. PubMed ID: 15345313 [TBL] [Abstract][Full Text] [Related]
17. Optimizing cellular immunity against HIV-1 Gag and preventing suppression by HIV-1 gp120. van Montfort T; Sanders RW Expert Rev Vaccines; 2012 Oct; 11(10):1175-7. PubMed ID: 23176650 [TBL] [Abstract][Full Text] [Related]
18. Antigenic competition in CD4 Kallas EG; Grunenberg NA; Yu C; Manso B; Pantaleo G; Casapia M; Baden LR; Valencia J; Sobieszczyk M; Van Tieu H; Allen M; Hural J; Graham BS; Kublin J; Gilbert PB; Corey L; Goepfert PA; McElrath MJ; Johnson RP; Huang Y; Frahm N Sci Transl Med; 2019 Nov; 11(519):. PubMed ID: 31748227 [TBL] [Abstract][Full Text] [Related]
19. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection. Pettersen FO; Taskén K; Kvale D Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784 [TBL] [Abstract][Full Text] [Related]
20. Loss of long term protection with the inclusion of HIV pol to a DNA vaccine encoding gag. Garrod TJ; Gargett T; Yu W; Major L; Burrell CJ; Wesselingh S; Suhrbier A; Grubor-Bauk B; Gowans EJ Virus Res; 2014 Nov; 192():25-33. PubMed ID: 25152448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]